Skip to main content
. 2016 Feb 12;11(2):e0148806. doi: 10.1371/journal.pone.0148806

Table 4. Impact of treatment with inhibitors of gastric acid secretion on study outcomes.

Time dependent, multivariate analysis.

HR 95% CI p Control variables
Enteric peritonitis Diabetes, Charlson, albumin, immunosuppression, hemoglobin, GFR
IGAS overall 1.33 1.02, 1.75 0.040
PPI 1.08 0.70, 1.66 0.74
H2A 1.45 0.92, 2.29 0.11
Infectious mortality Age, diabetes, Charlson, albumin, immunosuppression, hemoglobin, GFR
IGAS overall 1.61 1.14, 2.27 0.007
PPI 0.90 0.52, 1.49 0.62
H2A 2.03 1.19, 3.47 0.01
Overall peritonitis Age, albumin, immunosuppression, GFR, hemoglobin, modality of PD
IGAS overall 1.09 0.95, 1.60 0.24
PPI 1.32 0.95, 1.66 0.17
H2A 0.97 0.74, 1.26 0.80
Overall mortality Age, diabetes, Charlson, albumin, immunosuppression, hemoglobin, GFR
IGAS overall 1.11 0.93, 1.31 0.24
PPI 0.94 0.76, 1.29 0.94
H2A 1.16 0.88, 1.53 0.31

IGAS: Inhibitors of gastric acid secretion; PPI: Proton pump inhibitors; H2A: H2 receptor antagonists.

* Independent predictors of outcome in best model. PD vintage NS

Time dependent Cox’s models. Figures denote adjusted hazard ratios (HR) with 95% confidence intervals and p values for the main outcome variables.